Industry Research Reports

Home > Reports > Chemical & Material > Axitinib API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Axitinib API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-06-16

Pages: 141 Pages

Report ld: 6785118

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Axitinib API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Axitinib API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Axitinib API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Axitinib API market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Axitinib API.

MARKET SEGMENTATION

By Company

Hunan Huateng Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Beijing Mesochem Technology
Guangdong Raffles PharmaTech
Hangzhou Longshine Bio-Tech
Shenzhen HwaGen Pharmaceutical
Alembic Pharmaceuticals
Anax Laboratories
Biotechnica Pharma
DEAFARMA
Hetero Drugs
MSN Laboratories
Shilpa Medicare

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

0.95
0.98
0.99
Others

Segment by Application

Injection
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Axitinib API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Axitinib API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Axitinib API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Axitinib API Product Introduction

1.2 Global Axitinib API Market Size Forecast

1.2.1 Global Axitinib API Sales Value (2021–2032)

1.2.2 Global Axitinib API Sales Volume (2021–2032)

1.2.3 Global Axitinib API Sales Price (2021–2032)

1.3 Axitinib API Market Trends & Drivers

1.3.1 Axitinib API Industry Trends

1.3.2 Axitinib API Market Drivers & Opportunities

1.3.3 Axitinib API Market Challenges

1.3.4 Axitinib API Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Axitinib API Players Revenue Ranking (2025)

2.2 Global Axitinib API Revenue by Company (2021–2026)

2.3 Global Axitinib API Sales Volume Ranking of Players (2025)

2.4 Global Axitinib API Sales Volume by Company (2021–2026)

2.5 Global Axitinib API Average Price by Company (2021–2026)

2.6 Key Manufacturers Axitinib API Manufacturing Base and Headquarters

2.7 Key Manufacturers Axitinib API Product Offerings

2.8 Key Manufacturers Start of Mass Production of Axitinib API

2.9 Axitinib API Market Competitive Analysis

2.9.1 Axitinib API Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Axitinib API Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Axitinib API revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Axitinib API Market Classification

3.1 Introduction by Type

3.1.1 0.95

3.1.2 0.98

3.1.3 0.99

3.1.4 Others

3.1.5 Global Axitinib API Sales Value by Type

3.1.5.1 Global Axitinib API Sales Value by Type (2021 vs 2025 vs 2032)

3.1.5.2 Global Axitinib API Sales Value, by Type (2021–2032)

3.1.5.3 Global Axitinib API Sales Value, by Type (%), 2021–2032

3.1.6 Global Axitinib API Sales Volume by Type

3.1.6.1 Global Axitinib API Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.6.2 Global Axitinib API Sales Volume, by Type (2021–2032)

3.1.6.3 Global Axitinib API Sales Volume, by Type (%), 2021–2032

3.1.7 Global Axitinib API Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Injection

4.1.2 Others

4.2 Global Axitinib API Sales Value by Application

4.2.1 Global Axitinib API Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Axitinib API Sales Value, by Application (2021–2032)

4.2.3 Global Axitinib API Sales Value, by Application (%), 2021–2032

4.3 Global Axitinib API Sales Volume by Application

4.3.1 Global Axitinib API Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Axitinib API Sales Volume, by Application (2021–2032)

4.3.3 Global Axitinib API Sales Volume, by Application (%), 2021–2032

4.4 Global Axitinib API Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Axitinib API Sales Value by Region

5.1.1 Global Axitinib API Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Axitinib API Sales Value by Region (2021–2026)

5.1.3 Global Axitinib API Sales Value by Region (2027–2032)

5.1.4 Global Axitinib API Sales Value by Region (%), 2021–2032

5.2 Global Axitinib API Sales Volume by Region

5.2.1 Global Axitinib API Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Axitinib API Sales Volume by Region (2021–2026)

5.2.3 Global Axitinib API Sales Volume by Region (2027–2032)

5.2.4 Global Axitinib API Sales Volume by Region (%), 2021–2032

5.3 Global Axitinib API Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Axitinib API Sales Value, 2021–2032

5.4.2 North America Axitinib API Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Axitinib API Sales Value, 2021–2032

5.5.2 Europe Axitinib API Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Axitinib API Sales Value, 2021–2032

5.6.2 Asia Pacific Axitinib API Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Axitinib API Sales Value, 2021–2032

5.7.2 South America Axitinib API Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Axitinib API Sales Value, 2021–2032

5.8.2 Middle East & Africa Axitinib API Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Axitinib API Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Axitinib API Sales Value and Sales Volume

6.2.1 Key Countries/Regions Axitinib API Sales Value, 2021–2032

6.2.2 Key Countries/Regions Axitinib API Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Axitinib API Sales Value, 2021–2032

6.3.2 United States Axitinib API Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Axitinib API Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Axitinib API Sales Value, 2021–2032

6.4.2 Europe Axitinib API Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Axitinib API Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Axitinib API Sales Value, 2021–2032

6.5.2 China Axitinib API Sales Value by Type (%), 2025 vs 2032

6.5.3 China Axitinib API Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Axitinib API Sales Value, 2021–2032

6.6.2 Japan Axitinib API Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Axitinib API Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Axitinib API Sales Value, 2021–2032

6.7.2 South Korea Axitinib API Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Axitinib API Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Axitinib API Sales Value, 2021–2032

6.8.2 Southeast Asia Axitinib API Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Axitinib API Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Axitinib API Sales Value, 2021–2032

6.9.2 India Axitinib API Sales Value by Type (%), 2025 vs 2032

6.9.3 India Axitinib API Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Hunan Huateng Pharmaceutical

7.1.1 Hunan Huateng Pharmaceutical Company Information

7.1.2 Hunan Huateng Pharmaceutical Introduction and Business Overview

7.1.3 Hunan Huateng Pharmaceutical Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Hunan Huateng Pharmaceutical Axitinib API Product Offerings

7.1.5 Hunan Huateng Pharmaceutical Recent Developments

7.2 Zhejiang Jiuzhou Pharmaceutical

7.2.1 Zhejiang Jiuzhou Pharmaceutical Company Information

7.2.2 Zhejiang Jiuzhou Pharmaceutical Introduction and Business Overview

7.2.3 Zhejiang Jiuzhou Pharmaceutical Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Zhejiang Jiuzhou Pharmaceutical Axitinib API Product Offerings

7.2.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments

7.3 Beijing Mesochem Technology

7.3.1 Beijing Mesochem Technology Company Information

7.3.2 Beijing Mesochem Technology Introduction and Business Overview

7.3.3 Beijing Mesochem Technology Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Beijing Mesochem Technology Axitinib API Product Offerings

7.3.5 Beijing Mesochem Technology Recent Developments

7.4 Guangdong Raffles PharmaTech

7.4.1 Guangdong Raffles PharmaTech Company Information

7.4.2 Guangdong Raffles PharmaTech Introduction and Business Overview

7.4.3 Guangdong Raffles PharmaTech Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Guangdong Raffles PharmaTech Axitinib API Product Offerings

7.4.5 Guangdong Raffles PharmaTech Recent Developments

7.5 Hangzhou Longshine Bio-Tech

7.5.1 Hangzhou Longshine Bio-Tech Company Information

7.5.2 Hangzhou Longshine Bio-Tech Introduction and Business Overview

7.5.3 Hangzhou Longshine Bio-Tech Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 Hangzhou Longshine Bio-Tech Axitinib API Product Offerings

7.5.5 Hangzhou Longshine Bio-Tech Recent Developments

7.6 Shenzhen HwaGen Pharmaceutical

7.6.1 Shenzhen HwaGen Pharmaceutical Company Information

7.6.2 Shenzhen HwaGen Pharmaceutical Introduction and Business Overview

7.6.3 Shenzhen HwaGen Pharmaceutical Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Shenzhen HwaGen Pharmaceutical Axitinib API Product Offerings

7.6.5 Shenzhen HwaGen Pharmaceutical Recent Developments

7.7 Alembic Pharmaceuticals

7.7.1 Alembic Pharmaceuticals Company Information

7.7.2 Alembic Pharmaceuticals Introduction and Business Overview

7.7.3 Alembic Pharmaceuticals Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Alembic Pharmaceuticals Axitinib API Product Offerings

7.7.5 Alembic Pharmaceuticals Recent Developments

7.8 Anax Laboratories

7.8.1 Anax Laboratories Company Information

7.8.2 Anax Laboratories Introduction and Business Overview

7.8.3 Anax Laboratories Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Anax Laboratories Axitinib API Product Offerings

7.8.5 Anax Laboratories Recent Developments

7.9 Biotechnica Pharma

7.9.1 Biotechnica Pharma Company Information

7.9.2 Biotechnica Pharma Introduction and Business Overview

7.9.3 Biotechnica Pharma Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Biotechnica Pharma Axitinib API Product Offerings

7.9.5 Biotechnica Pharma Recent Developments

7.10 DEAFARMA

7.10.1 DEAFARMA Company Information

7.10.2 DEAFARMA Introduction and Business Overview

7.10.3 DEAFARMA Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 DEAFARMA Axitinib API Product Offerings

7.10.5 DEAFARMA Recent Developments

7.11 Hetero Drugs

7.11.1 Hetero Drugs Company Information

7.11.2 Hetero Drugs Introduction and Business Overview

7.11.3 Hetero Drugs Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 Hetero Drugs Axitinib API Product Offerings

7.11.5 Hetero Drugs Recent Developments

7.12 MSN Laboratories

7.12.1 MSN Laboratories Company Information

7.12.2 MSN Laboratories Introduction and Business Overview

7.12.3 MSN Laboratories Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.12.4 MSN Laboratories Axitinib API Product Offerings

7.12.5 MSN Laboratories Recent Developments

7.13 Shilpa Medicare

7.13.1 Shilpa Medicare Company Information

7.13.2 Shilpa Medicare Introduction and Business Overview

7.13.3 Shilpa Medicare Axitinib API Sales, Revenue, Price and Gross Margin (2021–2026)

7.13.4 Shilpa Medicare Axitinib API Product Offerings

7.13.5 Shilpa Medicare Recent Developments

8 Industry Chain Analysis

8.1 Axitinib API Industrial Chain

8.2 Axitinib API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Axitinib API Sales Model

8.5.2 Sales Channels

8.5.3 Axitinib API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Axitinib API Market Trends

Table 2. Axitinib API Market Drivers & Opportunities

Table 3. Axitinib API Market Challenges

Table 4. Axitinib API Market Restraints

Table 5. Global Axitinib API Revenue by Company (US$ Million), 2021–2026

Table 6. Global Axitinib API Revenue Market Share by Company (2021–2026)

Table 7. Global Axitinib API Sales Volume by Company (Tons), 2021–2026

Table 8. Global Axitinib API Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Axitinib API Price by Company (US$/Kg), 2021–2026

Table 10. Key Manufacturers Axitinib API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Axitinib API Product Type

Table 12. Key Manufacturers Start of Mass Production of Axitinib API

Table 13. Global Axitinib API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Axitinib API revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Axitinib API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Axitinib API Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Axitinib API Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Axitinib API Sales Market Share in Value by Type (2021–2026)

Table 20. Global Axitinib API Sales Market Share in Value by Type (2027–2032)

Table 21. Global Axitinib API Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)

Table 22. Global Axitinib API Sales Volume by Type (Tons), 2021–2026

Table 23. Global Axitinib API Sales Volume by Type (Tons), 2027–2032

Table 24. Global Axitinib API Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Axitinib API Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Axitinib API Price by Type (US$/Kg), 2021–2026

Table 27. Global Axitinib API Price by Type (US$/Kg), 2027–2032

Table 28. Global Axitinib API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Axitinib API Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Axitinib API Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Axitinib API Sales Market Share in Value by Application (2021–2026)

Table 32. Global Axitinib API Sales Market Share in Value by Application (2027–2032)

Table 33. Global Axitinib API Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)

Table 34. Global Axitinib API Sales Volume by Application (Tons), 2021–2026

Table 35. Global Axitinib API Sales Volume by Application (Tons), 2027–2032

Table 36. Global Axitinib API Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Axitinib API Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Axitinib API Price by Application (US$/Kg), 2021–2026

Table 39. Global Axitinib API Price by Application (US$/Kg), 2027–2032

Table 40. Global Axitinib API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Axitinib API Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Axitinib API Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Axitinib API Sales Value by Region (%), 2021–2026

Table 44. Global Axitinib API Sales Value by Region (%), 2027–2032

Table 45. Global Axitinib API Sales Volume by Region (Tons): 2021 vs 2025 vs 2032

Table 46. Global Axitinib API Sales Volume by Region (Tons), 2021–2026

Table 47. Global Axitinib API Sales Volume by Region (Tons), 2027–2032

Table 48. Global Axitinib API Sales Volume by Region (%), 2021–2026

Table 49. Global Axitinib API Sales Volume by Region (%), 2027–2032

Table 50. Global Axitinib API Average Price by Region (US$/Kg), 2021–2026

Table 51. Global Axitinib API Average Price by Region (US$/Kg), 2027–2032

Table 52. Key Countries/Regions Axitinib API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Axitinib API Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Axitinib API Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Axitinib API Sales Volume, (Tons), 2021–2026

Table 56. Key Countries/Regions Axitinib API Sales Volume, (Tons), 2027–2032

Table 57. Hunan Huateng Pharmaceutical Company Information

Table 58. Hunan Huateng Pharmaceutical Introduction and Business Overview

Table 59. Hunan Huateng Pharmaceutical Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 60. Hunan Huateng Pharmaceutical Axitinib API Product Offerings

Table 61. Hunan Huateng Pharmaceutical Recent Developments

Table 62. Zhejiang Jiuzhou Pharmaceutical Company Information

Table 63. Zhejiang Jiuzhou Pharmaceutical Introduction and Business Overview

Table 64. Zhejiang Jiuzhou Pharmaceutical Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 65. Zhejiang Jiuzhou Pharmaceutical Axitinib API Product Offerings

Table 66. Zhejiang Jiuzhou Pharmaceutical Recent Developments

Table 67. Beijing Mesochem Technology Company Information

Table 68. Beijing Mesochem Technology Introduction and Business Overview

Table 69. Beijing Mesochem Technology Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 70. Beijing Mesochem Technology Axitinib API Product Offerings

Table 71. Beijing Mesochem Technology Recent Developments

Table 72. Guangdong Raffles PharmaTech Company Information

Table 73. Guangdong Raffles PharmaTech Introduction and Business Overview

Table 74. Guangdong Raffles PharmaTech Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 75. Guangdong Raffles PharmaTech Axitinib API Product Offerings

Table 76. Guangdong Raffles PharmaTech Recent Developments

Table 77. Hangzhou Longshine Bio-Tech Company Information

Table 78. Hangzhou Longshine Bio-Tech Introduction and Business Overview

Table 79. Hangzhou Longshine Bio-Tech Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 80. Hangzhou Longshine Bio-Tech Axitinib API Product Offerings

Table 81. Hangzhou Longshine Bio-Tech Recent Developments

Table 82. Shenzhen HwaGen Pharmaceutical Company Information

Table 83. Shenzhen HwaGen Pharmaceutical Introduction and Business Overview

Table 84. Shenzhen HwaGen Pharmaceutical Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 85. Shenzhen HwaGen Pharmaceutical Axitinib API Product Offerings

Table 86. Shenzhen HwaGen Pharmaceutical Recent Developments

Table 87. Alembic Pharmaceuticals Company Information

Table 88. Alembic Pharmaceuticals Introduction and Business Overview

Table 89. Alembic Pharmaceuticals Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 90. Alembic Pharmaceuticals Axitinib API Product Offerings

Table 91. Alembic Pharmaceuticals Recent Developments

Table 92. Anax Laboratories Company Information

Table 93. Anax Laboratories Introduction and Business Overview

Table 94. Anax Laboratories Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 95. Anax Laboratories Axitinib API Product Offerings

Table 96. Anax Laboratories Recent Developments

Table 97. Biotechnica Pharma Company Information

Table 98. Biotechnica Pharma Introduction and Business Overview

Table 99. Biotechnica Pharma Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 100. Biotechnica Pharma Axitinib API Product Offerings

Table 101. Biotechnica Pharma Recent Developments

Table 102. DEAFARMA Company Information

Table 103. DEAFARMA Introduction and Business Overview

Table 104. DEAFARMA Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 105. DEAFARMA Axitinib API Product Offerings

Table 106. DEAFARMA Recent Developments

Table 107. Hetero Drugs Company Information

Table 108. Hetero Drugs Introduction and Business Overview

Table 109. Hetero Drugs Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 110. Hetero Drugs Axitinib API Product Offerings

Table 111. Hetero Drugs Recent Developments

Table 112. MSN Laboratories Company Information

Table 113. MSN Laboratories Introduction and Business Overview

Table 114. MSN Laboratories Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 115. MSN Laboratories Axitinib API Product Offerings

Table 116. MSN Laboratories Recent Developments

Table 117. Shilpa Medicare Company Information

Table 118. Shilpa Medicare Introduction and Business Overview

Table 119. Shilpa Medicare Axitinib API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 120. Shilpa Medicare Axitinib API Product Offerings

Table 121. Shilpa Medicare Recent Developments

Table 122. Key Raw Materials Lists

Table 123. Key Suppliers of Raw Materials Lists

Table 124. Axitinib API Downstream Customers

Table 125. Axitinib API Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Axitinib API Product Picture

Figure 2. Global Axitinib API Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Axitinib API Sales Value (US$ Million), 2021–2032

Figure 4. Global Axitinib API Sales Volume (Tons), 2021–2032

Figure 5. Global Axitinib API Sales Price (US$/Kg), 2021–2032

Figure 6. Axitinib API Report Years Considered

Figure 7. Global Axitinib API Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Axitinib API Sales Volume Ranking of Players (Tons), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Axitinib API Revenue in 2025

Figure 10. Axitinib API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. 0.95 Picture

Figure 12. 0.98 Picture

Figure 13. 0.99 Picture

Figure 14. Others Picture

Figure 15. Global Axitinib API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Axitinib API Sales Value Market Share by Type, 2025 & 2032

Figure 17. Global Axitinib API Sales Volume by Type (Tons), 2021 vs 2025 vs 2032

Figure 18. Global Axitinib API Sales Volume Market Share by Type, 2025 & 2032

Figure 19. Global Axitinib API Price by Type (US$/Kg), 2021–2032

Figure 20. Product Picture of Injection

Figure 21. Product Picture of Others

Figure 22. Global Axitinib API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Axitinib API Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Axitinib API Sales Volume by Application (Tons), 2021 vs 2025 vs 2032

Figure 25. Global Axitinib API Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Axitinib API Price by Application (US$/Kg), 2021–2032

Figure 27. North America Axitinib API Sales Value (US$ Million), 2021–2032

Figure 28. North America Axitinib API Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Axitinib API Sales Value (US$ Million), 2021–2032

Figure 30. Europe Axitinib API Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Axitinib API Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Axitinib API Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Axitinib API Sales Value (US$ Million), 2021–2032

Figure 34. South America Axitinib API Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Axitinib API Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Axitinib API Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Axitinib API Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Axitinib API Sales Volume (%), 2021–2032

Figure 39. United States Axitinib API Sales Value (US$ Million), 2021–2032

Figure 40. United States Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Axitinib API Sales Value (US$ Million), 2021–2032

Figure 43. Europe Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 45. China Axitinib API Sales Value (US$ Million), 2021–2032

Figure 46. China Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 47. China Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Axitinib API Sales Value (US$ Million), 2021–2032

Figure 49. Japan Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Axitinib API Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Axitinib API Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 57. India Axitinib API Sales Value (US$ Million), 2021–2032

Figure 58. India Axitinib API Sales Value by Type (%), 2025 vs 2032

Figure 59. India Axitinib API Sales Value by Application (%), 2025 vs 2032

Figure 60. Axitinib API Industrial Chain

Figure 61. Axitinib API Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Axitinib API market? zhanKai

The top companies in the global Axitinib API market are Hunan Huateng Pharmaceutical、Zhejiang Jiuzhou Pharmaceutical、Beijing Mesochem Technology.

Related Reports

Global Axitinib API Market Research Report 2026
The global Axitinib API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 140
USD 2900.00
(Single User License)
Global Axitinib API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Axitinib API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 96
USD 4250.00
(Single User License)
Global Axitinib API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Axitinib API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 161
USD 4900.00
(Single User License)
Axitinib API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Axitinib API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
Global Axitinib API Market Research Report 2025
The global market for Axitinib API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 97
USD 2900.00
(Single User License)
Global Axitinib API Market Research Report 2024
The global Axitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 98
USD 2900.00
(Single User License)

Global Axitinib API Market Research Report 2026
The global Axitinib API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 140
USD 2900.00 (Single User License)
Global Axitinib API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Axitinib API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 96
USD 4250.00 (Single User License)
Global Axitinib API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Axitinib API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 161
USD 4900.00 (Single User License)
Axitinib API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Axitinib API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
USD 3950.00 (Single User License)
Global Axitinib API Market Research Report 2025
The global market for Axitinib API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 97
USD 2900.00 (Single User License)
Global Axitinib API Market Research Report 2024
The global Axitinib API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 98
USD 2900.00 (Single User License)